Chronic Obstructive Pulmonary Disorder (COPD) Market Report

Global and Region Chronic Obstructive Pulmonary Disorder (COPD) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：194
  • REPORT CODE：GMM893699
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chronic Obstructive Pulmonary Disorder (COPD) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Obstructive Pulmonary Disorder (COPD)market, defines the market attractiveness level of Chronic Obstructive Pulmonary Disorder (COPD) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chronic Obstructive Pulmonary Disorder (COPD) industry, describes the types of Chronic Obstructive Pulmonary Disorder (COPD) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Obstructive Pulmonary Disorder (COPD) market and the development prospects and opportunities of Chronic Obstructive Pulmonary Disorder (COPD) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Obstructive Pulmonary Disorder (COPD) market in Chapter 13.

    By Player:

    • Teva Pharmaceutical Industries Ltd

    • Almirall

    • Pfizer

    • GlaxoSmithKline

    • Astellas Pharma

    • Boehringer Ingelheim

    • Novartis AG

    • Circassia Pharmaceuticals

    • AstraZeneca

    • Abbott Laboratories

    By Type:

    • Emphysema

    • Chronic Bronchitis

    By End-User:

    • Hospitals and Clinics

    • Homecare Settings

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chronic Obstructive Pulmonary Disorder (COPD) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chronic Obstructive Pulmonary Disorder (COPD) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chronic Obstructive Pulmonary Disorder (COPD) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chronic Obstructive Pulmonary Disorder (COPD) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis and Outlook to 2022

    • 7.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Consumption (2017-2022)

    • 7.2 United States Chronic Obstructive Pulmonary Disorder (COPD) Consumption (2017-2022)

    • 7.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Consumption (2017-2022)

    • 7.4 China Chronic Obstructive Pulmonary Disorder (COPD) Consumption (2017-2022)

    • 7.5 Japan Chronic Obstructive Pulmonary Disorder (COPD) Consumption (2017-2022)

    • 7.6 India Chronic Obstructive Pulmonary Disorder (COPD) Consumption (2017-2022)

    • 7.7 South Korea Chronic Obstructive Pulmonary Disorder (COPD) Consumption (2017-2022)

    8 Region and Country-wise Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis and Outlook to 2028

    • 8.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast (2022-2028)

    • 8.2 United States Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast (2022-2028)

    • 8.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast (2022-2028)

    • 8.4 China Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast (2022-2028)

    • 8.5 Japan Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast (2022-2028)

    • 8.6 India Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast (2022-2028)

    • 8.7 South Korea Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast (2022-2028)

    9 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Outlook by Types and Applications to 2022

    • 9.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Emphysema Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Chronic Bronchitis Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Homecare Settings Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Outlook by Types and Applications to 2028

    • 10.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Emphysema Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Chronic Bronchitis Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Homecare Settings Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chronic Obstructive Pulmonary Disorder (COPD) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chronic Obstructive Pulmonary Disorder (COPD) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Competitive Analysis

    • 14.1 Teva Pharmaceutical Industries Ltd

      • 14.1.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.1.2 Teva Pharmaceutical Industries Ltd Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Teva Pharmaceutical Industries Ltd Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.2 Almirall

      • 14.2.1 Almirall Company Details

      • 14.2.2 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.3 Pfizer

      • 14.3.1 Pfizer Company Details

      • 14.3.2 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.4 GlaxoSmithKline

      • 14.4.1 GlaxoSmithKline Company Details

      • 14.4.2 GlaxoSmithKline Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.5 Astellas Pharma

      • 14.5.1 Astellas Pharma Company Details

      • 14.5.2 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.6 Boehringer Ingelheim

      • 14.6.1 Boehringer Ingelheim Company Details

      • 14.6.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.7 Novartis AG

      • 14.7.1 Novartis AG Company Details

      • 14.7.2 Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.8 Circassia Pharmaceuticals

      • 14.8.1 Circassia Pharmaceuticals Company Details

      • 14.8.2 Circassia Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Circassia Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.9 AstraZeneca

      • 14.9.1 AstraZeneca Company Details

      • 14.9.2 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • 14.10 Abbott Laboratories

      • 14.10.1 Abbott Laboratories Company Details

      • 14.10.2 Abbott Laboratories Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Abbott Laboratories Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chronic Obstructive Pulmonary Disorder (COPD)

    • Figure Chronic Obstructive Pulmonary Disorder (COPD) Picture

    • Table Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Consumption by Country (2017-2022)

    • Figure United States Chronic Obstructive Pulmonary Disorder (COPD) Consumption and Growth Rate (2017-2022)

    • Table Europe Chronic Obstructive Pulmonary Disorder (COPD) Consumption and Growth Rate (2017-2022)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Consumption and Growth Rate (2017-2022)

    • Figure Japan Chronic Obstructive Pulmonary Disorder (COPD) Consumption and Growth Rate (2017-2022)

    • Figure India Chronic Obstructive Pulmonary Disorder (COPD) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chronic Obstructive Pulmonary Disorder (COPD) Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast by Country (2022-2028)

    • Figure United States Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chronic Obstructive Pulmonary Disorder (COPD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Emphysema Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Bronchitis Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Settings Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Emphysema Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Bronchitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Settings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chronic Obstructive Pulmonary Disorder (COPD) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chronic Obstructive Pulmonary Disorder (COPD) Export by Region (Top 5 Countries) (2017-2028)

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table Almirall (Foundation Year, Company Profile and etc.)

    • Table Almirall Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Almirall Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table Circassia Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Circassia Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Circassia Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Chronic Obstructive Pulmonary Disorder (COPD) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US